| scholarly article | Q13442814 |
| P50 | author | Anna Kirjavainen | Q64438310 |
| Francisco R. López-Picón | Q77359956 | ||
| Merja Haaparanta-Solin | Q88737197 | ||
| P2093 | author name string | Olof Solin | |
| Sarita Forsback | |||
| Dan Peters | |||
| Jatta S Takkinen | |||
| P2860 | cites work | 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation. | Q47952109 |
| Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography | Q48135023 | ||
| Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. | Q48451835 | ||
| A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances | Q48464576 | ||
| [11C]NS8880, a promising PET radiotracer targeting the norepinephrine transporter | Q48602110 | ||
| Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. | Q51029305 | ||
| The spectrum of behavioral changes in Alzheimer's disease. | Q53210662 | ||
| Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor | Q69314151 | ||
| Synthesis of 11C-labeled desipramine and its metabolite 2-hydroxydesipramine: potential radiotracers for PET studies of the norepinephrine transporter | Q74037939 | ||
| The Human BNST: Functional Role in Anxiety and Addiction | Q28081635 | ||
| Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter | Q34332440 | ||
| Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. | Q34390162 | ||
| Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboons. | Q34421101 | ||
| Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C | Q34431400 | ||
| Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. | Q34490657 | ||
| PET imaging of norepinephrine transporters | Q34577710 | ||
| Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. | Q34874501 | ||
| Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders | Q36719172 | ||
| Neural reserve, neuronal density in the locus ceruleus, and cognitive decline | Q36953042 | ||
| Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates | Q37009798 | ||
| Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET. | Q37105874 | ||
| Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter | Q37352287 | ||
| Locus (coeruleus) minoris resistentiae in pathogenesis of Alzheimer's disease | Q38267158 | ||
| Neuroanatomy and pathology of sporadic Alzheimer's disease | Q38446411 | ||
| PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-18F-FMeNER-D2. | Q39097209 | ||
| The human locus coeruleus: computer reconstruction of cellular distribution | Q41279154 | ||
| Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases | Q42438205 | ||
| Noradrenergic changes, aggressive behavior, and cognition in patients with dementia | Q43923762 | ||
| PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain | Q44916198 | ||
| Development of the norepinephrine transporter in the rat CNS. | Q45160924 | ||
| Ethnic differences in the prevalence and pattern of dementia-related behaviors | Q46134990 | ||
| Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery | Q46503348 | ||
| Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. | Q46683965 | ||
| Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram | Q46831650 | ||
| PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole | Q46925568 | ||
| Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice | Q47580999 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | norepinephrine | Q186242 |
| P304 | page(s) | 11-19 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats | |
| P478 | volume | 9 |
Search more.